Amenamevir
Amenamevir is an antiviral drug used for the treatment of shingles.
It acts as an inhibitor of the zoster virus's helicase–primase complex. Amenamevir was approved in Japan for the treatment of shingles in 2017.
Amenamevir is an antiviral drug used for the treatment of shingles.
It acts as an inhibitor of the zoster virus's helicase–primase complex. Amenamevir was approved in Japan for the treatment of shingles in 2017.